Delivery Order SPE2DB24D2205-SPE2DB24FDVHW
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a period ending on July 31, 2024. The firm-fixed-price contract has a ceiling value of $8,379.09. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,379.09 and runs through July 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the U.S. Defense Department's Medical Supply Chain agency. The $16,758.18 firm fixed-price delivery order contract has a completion date of May 6, 2024 and was awarded on April 15, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract, valued at $5,586.06, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $11,213.60, is a firm fixed price delivery order with a period of performance through July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,082.67 for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through February 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,595.00 and an ultimate completion date of June 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. The award is a Firm Fixed Price Delivery Order, with a ceiling value of $2,793.03 and a period of performance through July 30, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a for-profit pharmaceutical distribution company, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a medical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $8,379.09, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTOR. The contract has a ceiling value of $11,172.12 and a period of performance through September 5, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., is providing these critical medical supplies to support...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDVHWDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a 2-year period from June 2024 to July 2024. The contract has a ceiling value of $8,379.09 and is structured as a firm-fixed price delivery order. Amerisourcebergen, a large pharmaceutical distribution company, is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that the company holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 6/10/24 |